Duopharma Biotech Berhad (KLSE: DPHARMA)

Market Cap	1.19B
Revenue (ttm)	787.53M
Net Income (ttm)	56.06M
Shares Out	961.94M
EPS (ttm)	0.06
PE Ratio	21.29
Forward PE	15.44
Dividend	0.03 (2.31%)
Ex-Dividend Date	Aug 29, 2024

Volume	147,900
Average Volume	316,485
Open	1.200
Previous Close	1.210
Day's Range	1.190 - 1.210
52-Week Range	1.100 - 1.450
Beta	0.70
RSI	47.12
Earnings Date	Feb 20, 2025

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty p...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,650
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2023, Duopharma Biotech Berhad's revenue was 704.73 million, an increase of 1.15% compared to the previous year's 696.72 million. Earnings were 52.65 million, a decrease of -24.91%.